相关实验视频

Updated: Jul 16, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

AP003352.1/miR-141-3p轴通过LPAR3增强骨髓瘤的扩散

Hongde Yu¹, Bolun Zhang¹, Lin Qi¹

¹Department of Orthopedics, Dalian NO.3 People's Hospital, Dalian, China.

|September 20, 2023

概括

一个涉及AP003352.1,miR-141-3p和LPAR3的新型ceRNA网络驱动骨髓瘤的进展. 这个轴有可能作为骨髓瘤的诊断标志物.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一种遗传学.

背景情况:

骨髓瘤 (OS) 是一种恶性骨瘤,发病率越来越高,预后不佳.
长非编码RNAs (lncRNAs) 和microRNAs (miRNAs) 通过竞争的内源RNA (ceRNA) 网络来调节OS的发展.
LPAR3基因在癌症进展中起作用,但其在OS中的调节机制尚不清楚.

研究的目的:

为了阐明ceRNA调节机制涉及LPAR3在骨髓瘤.
研究AP003352.1/miR-141-3p轴在骨髓瘤进展中的作用.
评估AP003352.1/miR-141-3p/LPAR3轴在骨肉瘤中的诊断潜力.

主要方法:

对基因表达和调控相互作用的分析.
研究涉及AP003352.1,miR-141-3p和LPAR3.3的ceRNA机制.
评估AP003352.1/miR-141-3p/LPAR3轴作为一个诊断标记.

主要成果:

这项研究确定了AP003352.1和miR-141-3p作为骨髓瘤中LPAR3表达的调节剂.
AP003352.1促进恶性骨髓瘤的进展,部分是通过其对miR-141-3p的调节.
AP003352.1/miR-141-3p/LPAR3轴显示出作为骨髓瘤多基因诊断标记物的潜力.

结论:

一个新的ceRNA调节网络,AP003352.1/miR-141-3p/LPAR3轴,对于骨髓瘤的进展至关重要.
这一监管轴为骨髓瘤诊断和治疗提供了一个新的潜在目标.
对该网络的进一步研究可能会导致骨髓瘤治疗策略的改进.

关键词:

这就是CeRNA.细胞的增殖细胞的增殖.在LPAR3中使用LPAR3.骨质肉瘤骨质肉瘤是什么

更多相关视频

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...